• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经皮组织工程肺动脉瓣支架植入术。

Percutaneous tissue-engineered pulmonary valved stent implantation.

机构信息

Department of Cardiovascular Surgery, Christian-Albrechts-University of Kiel, School of Medicine, Kiel, Germany.

出版信息

Ann Thorac Surg. 2010 Jan;89(1):259-63. doi: 10.1016/j.athoracsur.2009.06.048.

DOI:10.1016/j.athoracsur.2009.06.048
PMID:20103248
Abstract

PURPOSE

The purpose of this study was to evaluate the feasibility of percutaneously implanted tissue-engineered valved stents in the ovine pulmonary valve position.

DESCRIPTION

Porcine pulmonary heart valves and small intestinal submucosa were obtained from a slaughterhouse, and the intestinal submucosa used to cover the inside of the porcine pulmonary valved stents. Endothelial cells and autologous myofibroblasts were obtained from carotid artery segments of juvenile sheep. After myofibroblast seeding, constructs were placed in a dynamic bioreactor system and were cultured for 16 days. After Endothelial cell seeding, the tissue-engineered valved stents were deployed into the pulmonary valve annular site. Angiography was performed at implantation and explantation (4 weeks). Constructs were analyzed macroscopically and microscopically.

EVALUATION

Orthotopic positioning of the stents (n = 3) at the time of implantation and explantation, as well as normal valve function, was observed through angiography. Gross morphology confirmed excellent opening and closing of all leaflets. Strong expression of alpha-smooth muscle actin in neointerstitial cells and of von-Willebrand-Factor in endothelial cells was revealed by immunocytochemistry.

CONCLUSIONS

This study demonstrates successful merging of two novel technologies: (1) percutaneous valved stent implantation and (2) tissue engineering of autologous heart valves.

摘要

目的

本研究旨在评估经皮植入组织工程化瓣状支架在羊肺动脉瓣位置的可行性。

描述

从屠宰场获得猪肺动脉瓣和小肠黏膜下层,并将肠黏膜下层用于覆盖猪肺动脉瓣状支架的内部。从幼年绵羊的颈动脉段获得内皮细胞和自体成纤维细胞。在成纤维细胞接种后,将构建体放置在动态生物反应器系统中培养 16 天。内皮细胞接种后,将组织工程化瓣状支架部署到肺动脉瓣环部位。在植入和取出时(4 周)进行血管造影。通过大体和显微镜分析来评估构建体。

评估

通过血管造影观察到支架在植入和取出时的原位定位(n = 3),以及正常的瓣膜功能。大体形态学证实了所有瓣叶的良好开闭。免疫细胞化学显示,新的间质细胞中α-平滑肌肌动蛋白的表达强烈,内皮细胞中 von-Willebrand-Factor 的表达强烈。

结论

本研究成功地融合了两项新技术:(1)经皮瓣状支架植入术和(2)自体心脏瓣膜的组织工程化。

相似文献

1
Percutaneous tissue-engineered pulmonary valved stent implantation.经皮组织工程肺动脉瓣支架植入术。
Ann Thorac Surg. 2010 Jan;89(1):259-63. doi: 10.1016/j.athoracsur.2009.06.048.
2
Percutaneous pulmonary valve replacement: autologous tissue-engineered valved stents.经皮肺动脉瓣置换术:自体组织工程瓣支架。
Cardiovasc Res. 2010 Dec 1;88(3):453-61. doi: 10.1093/cvr/cvq212. Epub 2010 Jul 1.
3
Prevention of device-related tissue damage during percutaneous deployment of tissue-engineered heart valves.经皮植入组织工程心脏瓣膜期间预防与器械相关的组织损伤。
J Thorac Cardiovasc Surg. 2006 Jun;131(6):1323-30. doi: 10.1016/j.jtcvs.2006.01.053.
4
Percutaneous pulmonary polyurethane valved stent implantation.经皮肺聚氨脂瓣状支架植入术。
J Thorac Cardiovasc Surg. 2010 Mar;139(3):748-52. doi: 10.1016/j.jtcvs.2009.08.013. Epub 2009 Oct 9.
5
Percutaneous tissue-engineered pulmonary valved stent implantation: comparison of bone marrow-derived CD133+-cells and cells obtained from carotid artery.经皮组织工程肺动脉瓣支架植入术:骨髓来源的 CD133+细胞与颈动脉细胞的比较。
Tissue Eng Part C Methods. 2013 May;19(5):363-74. doi: 10.1089/ten.TEC.2012.0078. Epub 2012 Dec 18.
6
[A xenogeneic acellularized matrix for heart valve tissue engineering: in vivo study in a sheep model].一种用于心脏瓣膜组织工程的异种脱细胞基质:绵羊模型的体内研究
Z Kardiol. 2003 Nov;92(11):938-46. doi: 10.1007/s00392-003-0978-4.
7
Invited commentary.特邀评论
Ann Thorac Surg. 2010 Jan;89(1):264. doi: 10.1016/j.athoracsur.2009.07.001.
8
Minimally-invasive implantation of living tissue engineered heart valves: a comprehensive approach from autologous vascular cells to stem cells.微创植入活组织工程心脏瓣膜:从自体血管细胞到干细胞的综合方法。
J Am Coll Cardiol. 2010 Aug 3;56(6):510-20. doi: 10.1016/j.jacc.2010.04.024.
9
Advances in experimental percutaneous pulmonary valve replacement.经皮肺动脉瓣置换术的实验进展
Ann Thorac Surg. 2005 Sep;80(3):969-75. doi: 10.1016/j.athoracsur.2005.03.041.
10
The in vitro development of autologous fibrin-based tissue-engineered heart valves through optimised dynamic conditioning.通过优化动态条件培养实现自体纤维蛋白基组织工程心脏瓣膜的体外发育
Biomaterials. 2007 Aug;28(23):3388-97. doi: 10.1016/j.biomaterials.2007.04.012. Epub 2007 Apr 13.

引用本文的文献

1
Calcification in Pulmonary Heart Valve Tissue Engineering: A Systematic Review and Meta-Analysis of Large-Animal Studies.肺动脉瓣组织工程中的钙化:大型动物研究的系统评价与荟萃分析
JACC Basic Transl Sci. 2023 Jan 25;8(5):572-591. doi: 10.1016/j.jacbts.2022.09.009. eCollection 2023 May.
2
Tissue Engineered Transcatheter Pulmonary Valved Stent Implantation: Current State and Future Prospect.组织工程经导管肺动脉瓣置入术:现状与未来展望。
Int J Mol Sci. 2022 Jan 10;23(2):723. doi: 10.3390/ijms23020723.
3
Pulmonary valve tissue engineering strategies in large animal models.
大动物模型中的肺动脉瓣组织工程策略。
PLoS One. 2021 Oct 5;16(10):e0258046. doi: 10.1371/journal.pone.0258046. eCollection 2021.
4
Polymeric trileaflet prosthetic heart valves: evolution and path to clinical reality.三叶型聚合物人工心脏瓣膜:发展与走向临床现实之路。
Expert Rev Med Devices. 2012 Nov;9(6):577-94. doi: 10.1586/erd.12.51.
5
Decellularized tissue-engineered heart valve leaflets with recellularization potential.具有再细胞化潜力的去细胞化组织工程心脏瓣膜叶瓣
Tissue Eng Part A. 2013 Mar;19(5-6):759-69. doi: 10.1089/ten.TEA.2012.0365. Epub 2012 Dec 10.
6
Tissue-engineered heart valve: future of cardiac surgery.组织工程心脏瓣膜:心脏外科手术的未来。
World J Surg. 2012 Jul;36(7):1581-91. doi: 10.1007/s00268-012-1535-y.
7
[Cell sources for cardiovascular tissue engineering].[心血管组织工程的细胞来源]
Chirurg. 2011 Apr;82(4):295-302. doi: 10.1007/s00104-010-2030-3.
8
Mesenchymal stem cells and progenitor cells in connective tissue engineering and regenerative medicine: is there a future for transplantation?结缔组织工程和再生医学中的间充质干细胞和祖细胞:移植有未来吗?
Langenbecks Arch Surg. 2011 Apr;396(4):489-97. doi: 10.1007/s00423-011-0762-2. Epub 2011 Mar 4.